TITLE:
A Study of an Investigational Medication for Severe Primary Hyperparathyroidism or Parathyroid Cancer

CONDITION:
Hyperparathyroidism

INTERVENTION:
AMG 073

SUMMARY:

      This study will assess an investigational medication for patients with severe primary
      hyperparathyroidism or parathyroid cancer.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        -  Patients must have parathyroid carcinoma or severe primary hyperparathyroidism; *
             Abnormally elevated calcium levels above 12.5 mg/dL; * Not be pregnant or nursing; *
             Not have had any type of cancer other than parathyroid carcinoma within the last 5
             years.
      
